Page last updated: 2024-12-05

3-aminobutyric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-aminobutyric acid, also known as GABA, is a neurotransmitter that plays a critical role in the central nervous system. It is synthesized from glutamate by the enzyme glutamate decarboxylase. GABA exerts inhibitory effects on neurons, reducing neuronal excitability and contributing to processes such as sleep, mood regulation, and motor control. GABA is studied extensively due to its involvement in various neurological disorders including anxiety, epilepsy, and Parkinson's disease. Its effects on mood and cognitive function make it a target for therapeutic interventions.'

3-aminobutyric acid: GABA uptake inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-aminobutanoic acid : A beta-amino acid that is butyric acid which is substituted by an amino group at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10932
CHEMBL ID1995111
CHEBI ID37081
SCHEMBL ID44574
MeSH IDM0137554

Synonyms (98)

Synonym
NCI60_041705
dl-3-amino-n-butyric acid
MLS000069399
smr000058404
3-aminobutanoic acid
beta-aminobutyric acid
541-48-0
3-aminobutyric acid
3-methyl-beta-alanine
CHEBI:37081 ,
nsc77380
butyric acid, (.+-.)-
(.+-.)-.beta.-aminobutyric acid
2835-82-7
dl-3-aminobutyric acid
dl-.beta.-aminobutyrate
nsc-77380
dl-.beta.-aminobutyric acid
3-aminobutanoic acid, 97%
einecs 208-783-2
einecs 220-617-0
butanoic acid, 3-amino-
ai3-26821
baba
A-5230
butyric acid, 3-amino-
0B9FE31A-1286-4B2B-B64E-4A3871898B12
A0281
FT-0650754
FT-0650753
A5389
3-amino-butyric acid
dl-beta-homo-alanine
CHEMBL1995111
A829994
dl-3-aminobutanoic acid
AKOS005174346
FT-0689095
4282sa5cts ,
nsc 77380
unii-4282sa5cts
FT-0625401
AM20100428
r-3-aminobutyric acid
SCHEMBL44574
.beta.-aminobutyric acid [mi]
(+/-)-3-aminobutanoic acid
(+/-)-.beta.-aminobutyric acid
(rs)-3-aminobutanoic acid
(+/-)-3-amino-n-butyric acid
carbocreatine
.beta.-aminobutyric acid, (+/-)-
butyric acid, .beta.-amino-
(+/-)-3-aminobutyric acid
.beta.-aminobutyric acid
3-methyl-.beta.-alanine
J-502211
h-beta-hoala-oh.hcl
SY019803
dl-beta-aminobutyric acid
J-640366
.beta.-amino-n-butyric acid
dl-.beta.-amino-n-butyric acid
butyric acid, 3-amino-, dl-
.beta.-methyl-.beta.-alanine
.beta.-aminobutanoic acid
dl-beta-aminobutyric acid dl-3-aminobutyric acid
DTXSID4040975
(+)-dimet 2,3-o-isopropylidened-tartrate
J-800369
mfcd00008087
3-aminobutanoic acid, vetec(tm) reagent grade, 97%
b-homoalanine
3-amino-(.+-.)-butyric acid
3-amino-(.+-.)-butanoic acid
3-amino-butanoic acid
dl-3-aminobutyric
3-amino-dl-butyric acid
(3r)-3-amino-butanoic acid
SY022577
4-amino-5-(2-methoxyphenyl)-2h-1,2,4-triazole-3-thione
Q3604567
SY022578
167222-96-0
(3s)-3-amino-butanoic acid
AS-11703
h-dl-abu(3)-oh
dolutegravir intermediates
EN300-23041
60625-83-4
3-aminopent-4-ynoic acid
tungsten(vi)oxychloride
AB87426
AB87563
CS-W009549
HY-W008833
butanoic acid, 3-amino-, (a+/-)-
Z147647144

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" We evaluated the phytotoxicity caused by the RS BABA (racemic mixture of R and S BABA), evaluating the dose-response effect and different modes of application on tomato."( β-Aminobutyric acid induced phytotoxicity and effectiveness against nematode is stereomer-specific and dose-dependent in tomato.
Ameye, M; Audenaert, K; Deveux, M; Haesaert, G; Kyndt, T; Rabasse, JM; Singh, RR; Spanoghe, P, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
beta-amino acidA non-proteinogenic amino acid in which the amino group is located on the carbon atom at the position beta to the carboxy group.
monocarboxylic acidAn oxoacid containing a single carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)50.11870.00011.753610.0000AID759056
Sodium- and chloride-dependent GABA transporter 1Mus musculus (house mouse)IC50 (µMol)50.11870.03712.19228.5114AID759056
Sodium- and chloride-dependent GABA transporter 2Mus musculus (house mouse)IC50 (µMol)46.77351.41255.26838.1283AID759053
Sodium- and chloride-dependent GABA transporter 3Mus musculus (house mouse)IC50 (µMol)83.17641.54883.67618.1283AID759054
Sodium- and chloride-dependent betaine transporterMus musculus (house mouse)IC50 (µMol)812.83100.18003.188010.0000AID759055
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (19)

Processvia Protein(s)Taxonomy
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (23)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (24)

Assay IDTitleYearJournalArticle
AID1092019Induction of systemic acquired resistance against Tobacco mosaic virus (TMV) in tobacco plants exposed to 100 ug/mL compound through leaf spray followed by 7 days culture under green house conditions assessed as inhibition of viral growth in leaves infect2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092030In vivo antiviral activity against Tobacco mosaic virus (TMV) infected tobacco leaves exposed to 100 ug/mL for 20 min assessed as inhibition of viral growth measured 72 hr post compound treatment compound by half-leaf juice rubbing method2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092014Induction of systemic acquired resistance against Tobacco mosaic virus (TMV) in tobacco plants exposed to 500 ug/mL compound through irrigation based soil treatment followed by 7 days culture under green house conditions assessed as inhibition of viral gr2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092033Antiviral activity against Tobacco mosaic virus (TMV) infected tobacco leaves exposed to 50 ug/mL for 20 min assessed as inhibition of viral growth measured 72 hr post compound treatment compound by half-leaf juice rubbing method2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID759053Inhibition of GABA uptake at murine GAT-2 expressed in HEK293 cells2013European journal of medicinal chemistry, Jul, Volume: 65Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors.
AID1092026Antiviral activity against Tobacco mosaic virus (TMV) infected tobacco leaves exposed to 1000 ug/mL for 20 min assessed as inhibition of viral growth measured 72 hr post compound treatment compound by half-leaf juice rubbing method2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID759054Inhibition of GABA uptake at murine GAT-3 expressed in HEK293 cells2013European journal of medicinal chemistry, Jul, Volume: 65Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors.
AID1092025Antiviral activity against Tobacco mosaic virus (TMV) infected tobacco leaves exposed to 2000 ug/mL for 20 min assessed as inhibition of viral growth measured 72 hr post compound treatment compound by half-leaf juice rubbing method2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092015Induction of systemic acquired resistance against Tobacco mosaic virus (TMV) in tobacco plants exposed to 1000 ug/mL compound through irrigation based soil treatment followed by 7 days culture under green house conditions assessed as inhibition of viral g2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092032Antiviral activity against Tobacco mosaic virus (TMV) infected tobacco leaves exposed to 100 ug/mL for 20 min assessed as inhibition of viral growth measured 72 hr post compound treatment compound by half-leaf juice rubbing method2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092013Induction of systemic acquired resistance against Tobacco mosaic virus (TMV) in tobacco plants exposed to 100 ug/mL compound through irrigation based soil treatment followed by 7 days culture under green house conditions assessed as inhibition of viral gr2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092020Induction of systemic acquired resistance against Tobacco mosaic virus (TMV) in tobacco plants exposed to 500 ug/mL compound through leaf spray followed by 7 days culture under green house conditions assessed as inhibition of viral growth in leaves infect2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID759055Inhibition of GABA uptake at murine BGT-1 expressed in HEK293 cells2013European journal of medicinal chemistry, Jul, Volume: 65Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors.
AID1092022In vivo antiviral activity against Tobacco mosaic virus (TMV) infected tobacco leaves exposed to 2000 ug/mL for 20 min assessed as inhibition of viral growth measured 72 hr post compound treatment compound by half-leaf juice rubbing method2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092016Induction of systemic acquired resistance against Tobacco mosaic virus (TMV) in tobacco plants exposed to 2000 ug/mL compound through leaf spray followed by 7 days culture under green house conditions assessed as inhibition of viral growth in leaves infec2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092031Antiviral activity against Tobacco mosaic virus (TMV) infected tobacco leaves exposed to 500 ug/mL for 20 min assessed as inhibition of viral growth measured 72 hr post compound treatment compound by half-leaf juice rubbing method2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092018Induction of systemic acquired resistance against Tobacco mosaic virus (TMV) in tobacco plants exposed to 50 ug/mL compound through leaf spray followed by 7 days culture under green house conditions assessed as inhibition of viral growth in leaves infecte2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092028In vivo antiviral activity against Tobacco mosaic virus (TMV) infected tobacco leaves exposed to 1000 ug/mL for 20 min assessed as inhibition of viral growth measured 72 hr post compound treatment compound by half-leaf juice rubbing method2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID759056Inhibition of GABA uptake at murine GAT-1 expressed in HEK293 cells2013European journal of medicinal chemistry, Jul, Volume: 65Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors.
AID1092012Induction of systemic acquired resistance against Tobacco mosaic virus (TMV) in tobacco plants exposed to 50 ug/mL compound through irrigation based soil treatment followed by 7 days culture under green house conditions assessed as inhibition of viral gro2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092027In vivo antiviral activity against Tobacco mosaic virus (TMV) infected tobacco leaves exposed to 50 ug/mL for 20 min assessed as inhibition of viral growth measured 72 hr post compound treatment compound by half-leaf juice rubbing method2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092021Induction of systemic acquired resistance against Tobacco mosaic virus (TMV) in tobacco plants exposed to 1000 ug/mL compound through leaf spray followed by 7 days culture under green house conditions assessed as inhibition of viral growth in leaves infec2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092029In vivo antiviral activity against Tobacco mosaic virus (TMV) infected tobacco leaves exposed to 500 ug/mL for 20 min assessed as inhibition of viral growth measured 72 hr post compound treatment compound by half-leaf juice rubbing method2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
AID1092010Induction of systemic acquired resistance against Tobacco mosaic virus (TMV) in tobacco plants exposed to 2000 ug/mL compound through irrigation based soil treatment followed by 7 days culture under green house conditions assessed as inhibition of viral g2009Journal of agricultural and food chemistry, May-27, Volume: 57, Issue:10
Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (108)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (6.48)18.7374
1990's0 (0.00)18.2507
2000's27 (25.00)29.6817
2010's53 (49.07)24.3611
2020's21 (19.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.43 (24.57)
Research Supply Index4.70 (2.92)
Research Growth Index6.26 (4.65)
Search Engine Demand Index44.79 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (2.75%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other106 (97.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]